1. Home
  2. PCRX vs DQ Comparison

PCRX vs DQ Comparison

Compare PCRX & DQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$22.74

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo DAQO New Energy Corp.

DQ

DAQO New Energy Corp.

HOLD

Current Price

$16.37

Market Cap

1.1B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCRX
DQ
Founded
2006
2006
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
2010
2010

Fundamental Metrics

Financial Performance
Metric
PCRX
DQ
Price
$22.74
$16.37
Analyst Decision
Strong Buy
Buy
Analyst Count
4
4
Target Price
$30.25
$28.91
AVG Volume (30 Days)
391.0K
770.6K
Earning Date
04-30-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
107.44
N/A
EPS
0.07
N/A
Revenue
$541,533,000.00
N/A
Revenue This Year
$6.78
$69.82
Revenue Next Year
$8.54
$34.34
P/E Ratio
$323.86
N/A
Revenue Growth
26.04
N/A
52 Week Low
$18.80
$13.60
52 Week High
$27.64
$36.59

Technical Indicators

Market Signals
Indicator
PCRX
DQ
Relative Strength Index (RSI) 44.55 37.62
Support Level $22.06 N/A
Resistance Level $23.95 $26.08
Average True Range (ATR) 0.92 0.77
MACD -0.07 0.01
Stochastic Oscillator 24.00 24.12

Price Performance

Historical Comparison
PCRX
DQ

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About DQ DAQO New Energy Corp.

Daqo New Energy Corp is a polysilicon manufacturer based in China. The company manufactures and sells high-purity polysilicon to manufacturers who use it to make ingots, cells, and modules for solar power solutions. The polysilicon is packaged to meet crucible stacking, pulling, and solidification needs. All of the company's revenues come from the People's Republic of China.

Share on Social Networks: